<bill session="115" type="h" number="3692" updated="2019-04-18T16:14:48Z">
  <state datetime="2017-09-07">REFERRED</state>
  <status>
    <introduced datetime="2017-09-07"/>
  </status>
  <introduced datetime="2017-09-07"/>
  <titles>
    <title type="official" as="introduced">To amend the Controlled Substances Act to provide for additional flexibility with respect to medication-assisted treatment for opioid use disorders, and for other purposes.</title>
    <title type="short" as="introduced">Addiction Treatment Access Improvement Act of 2017</title>
    <title type="short" as="introduced">Addiction Treatment Access Improvement Act of 2017</title>
    <title type="display">Addiction Treatment Access Improvement Act of 2017</title>
  </titles>
  <sponsor bioguide_id="T000469"/>
  <cosponsors>
    <cosponsor bioguide_id="B001278" joined="2017-10-02"/>
    <cosponsor bioguide_id="C001072" joined="2018-06-05"/>
    <cosponsor bioguide_id="C001101" joined="2018-06-07"/>
    <cosponsor bioguide_id="C001067" joined="2018-02-27"/>
    <cosponsor bioguide_id="C001077" joined="2018-06-05"/>
    <cosponsor bioguide_id="C001092" joined="2017-11-16"/>
    <cosponsor bioguide_id="C001105" joined="2018-01-30"/>
    <cosponsor bioguide_id="C001114" joined="2018-04-26"/>
    <cosponsor bioguide_id="D000624" joined="2018-05-24"/>
    <cosponsor bioguide_id="E000179" joined="2018-05-24"/>
    <cosponsor bioguide_id="E000215" joined="2018-06-05"/>
    <cosponsor bioguide_id="F000464" joined="2017-09-25"/>
    <cosponsor bioguide_id="F000466" joined="2018-05-24"/>
    <cosponsor bioguide_id="G000582" joined="2018-07-11"/>
    <cosponsor bioguide_id="H001038" joined="2018-05-08"/>
    <cosponsor bioguide_id="J000298" joined="2018-05-24"/>
    <cosponsor bioguide_id="K000009" joined="2018-05-24"/>
    <cosponsor bioguide_id="K000379" joined="2017-11-16"/>
    <cosponsor bioguide_id="K000381" joined="2018-07-11"/>
    <cosponsor bioguide_id="K000210" joined="2018-06-05"/>
    <cosponsor bioguide_id="K000382" joined="2018-04-10"/>
    <cosponsor bioguide_id="L000567" joined="2017-11-14"/>
    <cosponsor bioguide_id="L000557" joined="2018-05-08"/>
    <cosponsor bioguide_id="L000397" joined="2018-12-11"/>
    <cosponsor bioguide_id="L000580" joined="2017-10-25"/>
    <cosponsor bioguide_id="L000570" joined="2017-09-07"/>
    <cosponsor bioguide_id="M001193" joined="2018-01-18"/>
    <cosponsor bioguide_id="M001163" joined="2018-05-24"/>
    <cosponsor bioguide_id="M001180" joined="2017-09-14"/>
    <cosponsor bioguide_id="M001166" joined="2018-06-05"/>
    <cosponsor bioguide_id="M001196" joined="2017-11-28"/>
    <cosponsor bioguide_id="M001202" joined="2018-04-17"/>
    <cosponsor bioguide_id="N000188" joined="2018-02-05"/>
    <cosponsor bioguide_id="N000147" joined="2018-03-19"/>
    <cosponsor bioguide_id="R000606" joined="2018-06-05"/>
    <cosponsor bioguide_id="R000486" joined="2018-02-05"/>
    <cosponsor bioguide_id="R000576" joined="2018-07-11"/>
    <cosponsor bioguide_id="S001145" joined="2018-06-08"/>
    <cosponsor bioguide_id="S000244" joined="2017-12-07"/>
    <cosponsor bioguide_id="S001170" joined="2018-01-29"/>
    <cosponsor bioguide_id="S001191" joined="2018-05-24"/>
    <cosponsor bioguide_id="S000480" joined="2018-01-30"/>
    <cosponsor bioguide_id="S001200" joined="2018-05-08"/>
    <cosponsor bioguide_id="S001196" joined="2017-09-13"/>
    <cosponsor bioguide_id="S001201" joined="2018-06-05"/>
    <cosponsor bioguide_id="T000467" joined="2018-01-10"/>
    <cosponsor bioguide_id="T000470" joined="2017-09-27"/>
    <cosponsor bioguide_id="T000463" joined="2018-06-08"/>
    <cosponsor bioguide_id="Y000062" joined="2018-04-11"/>
  </cosponsors>
  <actions>
    <action datetime="2017-09-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-09-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-09-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-09-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2017-09-21">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
    <action datetime="2018-04-25">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Markup, Referral"/>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="Crime, Terrorism, and Homeland Security" code="HSJU08" name="House Judiciary" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="4938"/>
    <bill type="s" session="115" relation="unknown" number="2317"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health personnel"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2017-09-07T04:00:00Z" status="Introduced in House">Addiction Treatment Access Improvement Act of 2017

This bill amends the Controlled Substances Act to revise the qualifications required for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.

It increases the maximum patient limit for a qualifying practitioner who meets certain requirements. The maximum patient limit is the maximum number of patients a qualifying practitioner can treat at one time.

The bill expands qualifying practitioners to include additional nonphysician practitioners: clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives.

It makes permanent the authorization for certain nonphysician practitioners to become qualifying practitioners.</summary>
  <committee-reports/>
</bill>
